A major clinical setback has sent Ultragenyx Pharmaceutical's stock to a fresh annual low. The catalyst was the failure of ...

The German wind turbine manufacturer Nordex finds itself at a crossroads, caught between robust operational results and ...

Following a recent decade-high, RWE's share price has entered a corrective phase. The utility giant's stock touched €58.52 in mid-March, a level not seen for te ...

ASML Holding NV has received a landmark order from South Korean memory chipmaker SK Hynix, significantly bolstering its order ...

While investment firm Bernstein has recently issued "Outperform" ratings for both Nvidia and Broadcom, its position on ...

A significant strategic move has been made in the natural resources sector, with billionaire investor Eric Sprott placing a ...

NRX Pharmaceuticals has concluded its 2025 fiscal year with a fundamentally restructured financial position. The company now enters a period defined by critical ...

All eyes are on Evotec SE as it prepares to release its complete 2025 annual report on April 8. This publication carries exceptional weight for the biotechnolog ...

Despite the significant anticipation for the upcoming Grand Theft Auto VI, investor sentiment remains unsettled. Broader ...

The capital strategy of British engineering group IMI PLC is receiving a notable vote of confidence from two significant ...

The spotlight turns to Genprex Inc. as the clinical-stage biotech firm prepares to unveil new preclinical data for its lead ...

A series of insider transactions at Hyatt Hotels Corporation is drawing market attention, creating a notable contrast with ...